Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Suzhou Fengbei Biotech Stock CoSHSE:603334 +3.65%40 Return-on-Tangible-Equity is 9.88% as of Mar. 2026, which is 56% below its 10-year median of 22.38. GuruFocus rates SHSE:603334 with a GF Score™ of 40/100. The stock has 4 warning signs investors should review. Among 224 Waste Management companies, Suzhou Fengbei Biotech Stock Co ranks better than 56.25% on this metric.
The historical rank and industry rank for Suzhou Fengbei Biotech Stock Co's Return-on-Tangible-Equity or its related term are showing as below:
SHSE:603334'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 11.79 Med: 22.38 Max: 34.05
Current: 11.79
During the past 6 years, Suzhou Fengbei Biotech Stock Co's highest Return-on-Tangible-Equity was 34.05%. The lowest was 11.79%. And the median was 22.38%.
SHSE:603334's Return-on-Tangible-Equity is ranked better than 56.25% of 224
companies
in the Waste Management industry
Industry Median: 9.995
vs SHSE:603334: 11.79
Suzhou Fengbei Biotech Stock Co (SHSE:603334) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Suzhou Fengbei Biotech Stock Co Return-on-Tangible-Equity Related Terms
Suzhou Fengbei Biotech Stock Co Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Suzhou Fengbei Biotech Stock Co Return-on-Tangible-Equity Chart
SHSE:603334 vs WM, RSG, WCN: Return-on-Tangible-Equity Comparison
For the Waste Management subindustry, Suzhou Fengbei Biotech Stock Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Suzhou Fengbei Biotech Stock Co Return-on-Tangible-Equity vs Waste Management Industry
For the Waste Management industry and Industrials sector, Suzhou Fengbei Biotech Stock Co's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Suzhou Fengbei Biotech Stock Co's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 9.88% mean?
Suzhou Fengbei Biotech Stock Co (SHSE:603334) has a Return-on-Tangible-Equity of 9.88% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Suzhou Fengbei Biotech Stock Co and its competitors. This is 56% below median its historical median of 22.38. Over the past decade, Suzhou Fengbei Biotech Stock Co's Return-on-Tangible-Equity has ranged from 11.79 to 34.05. According to the industry distribution chart, Suzhou Fengbei Biotech Stock Co ranks #98 out of 224 companies in the Waste Management industry, placing it in the top 43.7%.
Is Suzhou Fengbei Biotech Stock Co's Return-on-Tangible-Equity too high?
Suzhou Fengbei Biotech Stock Co's current Return-on-Tangible-Equity of 9.88% is 56% below median its 10-year median of 22.38. Over the past 10 years, this metric has ranged from a low of 11.79 to a high of 34.05. The Waste Management industry median Return-on-Tangible-Equity is 10.00. Suzhou Fengbei Biotech Stock Co's value of 9.88% is 1.2% below this industry median. Based on the distribution chart, Suzhou Fengbei Biotech Stock Co ranks #98 out of 224 companies in the Waste Management industry, which is above the industry midpoint. Overall, Suzhou Fengbei Biotech Stock Co has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does Suzhou Fengbei Biotech Stock Co's Return-on-Tangible-Equity compare to WM and RSG?
According to the Waste Management industry distribution chart, Suzhou Fengbei Biotech Stock Co ranks #98 out of 224 companies for Return-on-Tangible-Equity. This puts Suzhou Fengbei Biotech Stock Co in the upper half of its industry. The industry median Return-on-Tangible-Equity is 10.00. Suzhou Fengbei Biotech Stock Co's value of 9.88% is 1.2% below this benchmark. Historically, Suzhou Fengbei Biotech Stock Co's own Return-on-Tangible-Equity has ranged from 11.79 to 34.05 over the past decade. While the company's 10-year median is 22.38 vs. the industry median of 10.00, Suzhou Fengbei Biotech Stock Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Waste Management company?
The median Return-on-Tangible-Equity among Waste Management companies is 10.00, based on 224 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Suzhou Fengbei Biotech Stock Co's current Return-on-Tangible-Equity of 9.88% is 1.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Suzhou Fengbei Biotech Stock Co and its competitors. For the Waste Management industry, the median Return-on-Tangible-Equity is 10.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Suzhou Fengbei Biotech Stock Co's current Return-on-Tangible-Equity is 9.88%, which is 56% below median its own 10-year median of 22.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Suzhou Fengbei Biotech Stock Co stock overvalued right now?
Suzhou Fengbei Biotech Stock Co (SHSE:603334) has a current Return-on-Tangible-Equity of 9.88%. The current Return-on-Tangible-Equity is 9.88%, which is 56% below median its 10-year median of 22.38 and 1.2% below the Waste Management industry median of 10.00. Suzhou Fengbei Biotech Stock Co's overall GF Score™ is 40/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Suzhou Fengbei Biotech Stock Co (SHSE:603334), the current Return-on-Tangible-Equity is 9.88% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Suzhou Fengbei Biotech Stock Co Business Description
Suzhou Fengbei Biotech Stock Co Ltd is focused on the comprehensive utilization of waste oil and fat resources. The company is engaged in the research and development, production, and sales of industrial packaging materials, methyl oleate, and methylated soybean oil (excluding food products). It operates as an independent import and export agent for various commodities and technologies. The company's licensed projects include Fertilizer production, and General projects include Technical services, technical development, technical consultation, technical exchange, technology transfer, and technology promotion. It is into the research and development of bio-organic fertilizers, compound microbial fertilizers, and bio-pesticide technology.
40GF Score
Get the complete analysis for SHSE:603334
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603334 has been successfully added to your 
